Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.671 USD | -4.22% | -0.50% | -6.81% |
Mar. 08 | Galecto, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Galecto Shares Climb After Bone Marrow Disease Treatment Trial Yields Positive Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.81% | 19M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- GLTO Stock
- News Galecto, Inc.
- Galecto : Resumes Recruitment in Phase 2b Trial of GB0139 to Treat Idiopathic Pulmonary Fibrosis